BUSINESS COMBINATIONS (Tables)

9 Months Ended

Oct. 29, 2016

Business Combinations [Abstract]

Schedule of preliminary purchase price allocation

A summary of the purchase price allocation for Reeves-Sain Drug Store, Inc. is as follows (dollars in thousands):

Total purchase consideration:
Cash	$	42,750
Notes payable	$	13,000
Contingent liability	$	1,000
Total purchase consideration	$	56,750
Allocation of the purchase consideration:
Accounts receivables	$	14,474
Inventory	$	2,005
Other assets	$	298
Goodwill	$	44,385
Identifiable intangible assets	$	18,180
Total assets acquired	$	79,342
Accounts payable	$	21,448
Other current liabilities	$	1,144
Total liabilities assumed	$	22,592
Net assets acquired	$	56,750

Schedule of identifiable intangible assets acquired

The following are the identifiable intangible assets acquired and their respective weighted average useful lives, as determined based on valuations (dollars in thousands):

	Amount		Weighted Average Life (Years)
Customer prescription files	$	7,820		4
Referral and relationships	$	1,400		2
Trade name	$	6,900		-
Non-compete agreements	$	1,800		8
Business licenses	$	260		1
	$	18,180

Schedule of earning per share

The 2016 unaudited results were not adjusted as the three locations’ results were already included in our consolidated statement of operations.

	Thirty-Nine Weeks Ended
	October 29,			October 31,
(in thousands, except per share data)	2016			2015
Revenue	$	1,595,696		$	1,643,477
Earnings		(44,065	)		(4,166	)
Basic and diluted earnings per share	$	(1.20	)	$	(0.11	)